1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with Gait Disorders, Animal in 2 studies
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine : A tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grabli, D | 1 |
| Karachi, C | 1 |
| Folgoas, E | 1 |
| Monfort, M | 1 |
| Tande, D | 1 |
| Clark, S | 1 |
| Civelli, O | 1 |
| Hirsch, EC | 1 |
| François, C | 1 |
| Campos-Romo, A | 1 |
| Ojeda-Flores, R | 1 |
| Moreno-Briseño, P | 1 |
| Fernandez-Ruiz, J | 1 |
2 other studies available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Gait Disorders, Animal
| Article | Year |
|---|---|
Gait disorders in parkinsonian monkeys with pedunculopontine nucleus lesions: a tale of two systems.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Cell Count; Cholinergic Neu | 2013 |
Quantitative evaluation of MPTP-treated nonhuman parkinsonian primates in the HALLWAY task.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Behavioral Sciences; Biomec | 2009 |